Mesalazine-Induced Myopericarditis in a Patient with a Recent Diagnosis of Crohn's Disease: Apropos of a Case
Overview
Affiliations
Mesalazine- (5-aminosalicylic acid-) containing products are a well-known treatment for inflammatory bowel disease, often as first line. Myocarditis is recognized as a very rare possible side effect of this drug treatment. We present a case of mesalazine-induced myopericarditis that was successfully improved by immediate cessation of the medication.
Appala N, Veeramachaneni H, Khare A, Sundar P Cureus. 2024; 16(1):e52587.
PMID: 38370999 PMC: 10874644. DOI: 10.7759/cureus.52587.
Cesa K, Cunningham C, Harris T, Sunseri W Cureus. 2022; 14(6):e26366.
PMID: 35911289 PMC: 9334219. DOI: 10.7759/cureus.26366.
A Rare Case of Mesalazine-Induced Acute Myocarditis in a 19-Year-Old Female With Ulcerative Colitis.
Ali A, Kumaravel Kanagavelu A, Rahimi A, Mehmood Z, Tariq A, Das T Cureus. 2022; 13(11):e20036.
PMID: 34987921 PMC: 8717744. DOI: 10.7759/cureus.20036.
Mesalamine-induced Myocarditis in a Young Athlete: Can He Run Again?.
Ibrahim A, Khalil C, Megaly M, Tawadros M, Mosleh W, Corbelli J Cureus. 2019; 11(1):e3978.
PMID: 30967978 PMC: 6440563. DOI: 10.7759/cureus.3978.
5-Aminosalicylic Acid-Associated Myocarditis and Pericarditis: A Narrative Review.
Brown G Can J Hosp Pharm. 2017; 69(6):466-472.
PMID: 28123193 PMC: 5242279.